Hyperbaric Treatment Shows Significant Clinical Improvements for Autism
|
By HospiMedica International staff writers Posted on 24 Mar 2009 |

Image: Autistic children receiving hyperbaric treatment (Photo courtesy of Bruce McKeeman).
A new study reports that hyperbaric treatment--inhaling up to 100% oxygen at a pressure greater than one atmosphere in a pressurized chamber--for children with autism has led to improvements in the condition.
Researchers at the International Child Development Resource Center (ICDRC, Melbourne, FL, USA), the Center for Autism Research and Education (Phoenix, AZ, USA), and four other centers in the United States conducted a randomized, controlled, double-blind trial that studied 62 children with autism, aged 2-7 years, to assess the efficacy of hyperbaric treatment. The children were randomly assigned to either 40 hours of hyperbaric treatment at 1.3 atmospheres and 24% oxygen (treatment group) or slightly pressurized room air at 1.03 atmospheres and 21% oxygen (non-treatment group). Clinical outcomes were evaluated by three different scales: the Clinical Global Impression (CGI) scale, the Aberrant Behavior Checklist (ABC), and the Autism Treatment Evaluation Checklist (ATEC).
The researchers found that after 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning, receptive language, social interaction, and eye contact; nine out of 30 children (30%) in the treatment group were rated as "very much improved" or "much improved", compared to two of 26 (8%) of controls; 24 out of 30 children (80%) in the treatment group improved compared to 10 out of 26 of controls. Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning, receptive language, and eye contact.
The researchers also found that children with autism in the treatment group had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children in the non-treatment group. On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech, but not in the control group. In the treatment group compared to the control group, mean changes on the ABC total score and subscales were similar except a greater number of children improved in irritability. On the ATEC, sensory/cognitive awareness significantly improved in the treatment group compared to the control group. Post-hoc analysis indicated that children over age 5 and children with lower initial autism severity had the most robust improvements. The hyperbaric treatment itself was safe and well tolerated. The study was published on March 13, 2009 in the open access journal, BMC Pediatrics, a publication of BioMed Central.
"Given the positive findings of this study, and the shortage of proven treatments for individuals with autism, parents who pursue hyperbaric treatment for their child with autism can be assured that it is a safe treatment modality at the pressure used in this study, and that it may improve certain autistic behaviors," concluded lead author Dan Rossignol, M.D., and colleagues.
Related Links:
International Child Development Resource Center
Center for Autism Research and Education
Researchers at the International Child Development Resource Center (ICDRC, Melbourne, FL, USA), the Center for Autism Research and Education (Phoenix, AZ, USA), and four other centers in the United States conducted a randomized, controlled, double-blind trial that studied 62 children with autism, aged 2-7 years, to assess the efficacy of hyperbaric treatment. The children were randomly assigned to either 40 hours of hyperbaric treatment at 1.3 atmospheres and 24% oxygen (treatment group) or slightly pressurized room air at 1.03 atmospheres and 21% oxygen (non-treatment group). Clinical outcomes were evaluated by three different scales: the Clinical Global Impression (CGI) scale, the Aberrant Behavior Checklist (ABC), and the Autism Treatment Evaluation Checklist (ATEC).
The researchers found that after 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning, receptive language, social interaction, and eye contact; nine out of 30 children (30%) in the treatment group were rated as "very much improved" or "much improved", compared to two of 26 (8%) of controls; 24 out of 30 children (80%) in the treatment group improved compared to 10 out of 26 of controls. Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning, receptive language, and eye contact.
The researchers also found that children with autism in the treatment group had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children in the non-treatment group. On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech, but not in the control group. In the treatment group compared to the control group, mean changes on the ABC total score and subscales were similar except a greater number of children improved in irritability. On the ATEC, sensory/cognitive awareness significantly improved in the treatment group compared to the control group. Post-hoc analysis indicated that children over age 5 and children with lower initial autism severity had the most robust improvements. The hyperbaric treatment itself was safe and well tolerated. The study was published on March 13, 2009 in the open access journal, BMC Pediatrics, a publication of BioMed Central.
"Given the positive findings of this study, and the shortage of proven treatments for individuals with autism, parents who pursue hyperbaric treatment for their child with autism can be assured that it is a safe treatment modality at the pressure used in this study, and that it may improve certain autistic behaviors," concluded lead author Dan Rossignol, M.D., and colleagues.
Related Links:
International Child Development Resource Center
Center for Autism Research and Education
Latest Critical Care News
- Origami Robots to Deliver Medicine Less Invasively and More Effectively
- Improved Cough-Detection Technology Aids Health Monitoring
- AI Identifies Children in ER Likely to Develop Sepsis Within 48 Hours
- New Radiofrequency Therapy Slows Glioblastoma Growth
- Battery-Free Wireless Multi-Sensing Platform Revolutionizes Pressure Injury Detection
- Multimodal AI to Revolutionize Cardiovascular Disease Diagnosis and Treatment
- AI System Reveals Hidden Diagnostic Patterns in Electronic Health Records
- Highly Sensitive On-Skin Sensing Monitor Detects Vitamin B6 and Glucose in Sweat
- Artificial Intelligence Revolutionizing Pediatric Anesthesia Management
- New Device Detects Tuberculosis DNA Directly in Exhaled Air
- New Menstrual Cup Could Detect Infections and Improve Diagnostics
- Engineered “Natural Killer” Cells Could Help Fight Cancer
- Faster Lymph Flow Predicts Better Response to Diuretics in Acute Heart Failure
- New Global Recommendations Aim to End Deaths from Postpartum Hemorrhage
- 'Flat-Line ECG' Indicates Poor Outcomes for Out-Of-Hospital Cardiac Arrest
- New Guidance to Improve Diagnosis and Management of Heart Failure During Pregnancy and Postpartum
Channels
Surgical Techniques
view channel
Novel Glue Prevents Complications After Breast Cancer Surgery
Seroma and prolonged lymphorrhea are among the most common complications following axillary lymphadenectomy in breast cancer patients. These postoperative issues can delay recovery and postpone the start... Read more
Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
Delivering medication directly to specific regions of the brain has long been a major challenge in treating neurological disorders. Current implants and infusion systems typically reach only one or two... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







